Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

The impact of metabolic endotoxaemia on the browning process in human adipocytes

F. Omran, AM. Murphy, AZ. Younis, I. Kyrou, J. Vrbikova, V. Hainer, P. Sramkova, M. Fried, G. Ball, G. Tripathi, S. Kumar, PG. McTernan, M. Christian

. 2023 ; 21 (1) : 154. [pub] 20230419

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc23011747

Grantová podpora
BB/P008879/2 Biotechnology and Biological Sciences Research Council - United Kingdom

BACKGROUND: Dysfunctional adipose tissue (AT) is known to contribute to the pathophysiology of metabolic disease, including type 2 diabetes mellitus (T2DM). This dysfunction may occur, in part, as a consequence of gut-derived endotoxaemia inducing changes in adipocyte mitochondrial function and reducing the proportion of BRITE (brown-in-white) adipocytes. Therefore, the present study investigated whether endotoxin (lipopolysaccharide; LPS) directly contributes to impaired human adipocyte mitochondrial function and browning in human adipocytes, and the relevant impact of obesity status pre and post bariatric surgery. METHODS: Human differentiated abdominal subcutaneous (AbdSc) adipocytes from participants with obesity and normal-weight participants were treated with endotoxin to assess in vitro changes in mitochondrial function and BRITE phenotype. Ex vivo human AbdSc AT from different groups of participants (normal-weight, obesity, pre- and 6 months post-bariatric surgery) were assessed for similar analyses including circulating endotoxin levels. RESULTS: Ex vivo AT analysis (lean & obese, weight loss post-bariatric surgery) identified that systemic endotoxin negatively correlated with BAT gene expression (p < 0.05). In vitro endotoxin treatment of AbdSc adipocytes (lean & obese) reduced mitochondrial dynamics (74.6% reduction; p < 0.0001), biogenesis (81.2% reduction; p < 0.0001) and the BRITE phenotype (93.8% reduction; p < 0.0001). Lean AbdSc adipocytes were more responsive to adrenergic signalling than obese AbdSc adipocytes; although endotoxin mitigated this response (92.6% reduction; p < 0.0001). CONCLUSIONS: Taken together, these data suggest that systemic gut-derived endotoxaemia contributes to both individual adipocyte dysfunction and reduced browning capacity of the adipocyte cell population, exacerbating metabolic consequences. As bariatric surgery reduces endotoxin levels and is associated with improving adipocyte functionality, this may provide further evidence regarding the metabolic benefits of such surgical interventions.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23011747
003      
CZ-PrNML
005      
20230801133318.0
007      
ta
008      
230718s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12916-023-02857-z $2 doi
035    __
$a (PubMed)37076885
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Omran, Farah $u Division of Biomedical Sciences, Warwick Medical School, University of Warwick, Coventry, CV2 2DX, UK
245    14
$a The impact of metabolic endotoxaemia on the browning process in human adipocytes / $c F. Omran, AM. Murphy, AZ. Younis, I. Kyrou, J. Vrbikova, V. Hainer, P. Sramkova, M. Fried, G. Ball, G. Tripathi, S. Kumar, PG. McTernan, M. Christian
520    9_
$a BACKGROUND: Dysfunctional adipose tissue (AT) is known to contribute to the pathophysiology of metabolic disease, including type 2 diabetes mellitus (T2DM). This dysfunction may occur, in part, as a consequence of gut-derived endotoxaemia inducing changes in adipocyte mitochondrial function and reducing the proportion of BRITE (brown-in-white) adipocytes. Therefore, the present study investigated whether endotoxin (lipopolysaccharide; LPS) directly contributes to impaired human adipocyte mitochondrial function and browning in human adipocytes, and the relevant impact of obesity status pre and post bariatric surgery. METHODS: Human differentiated abdominal subcutaneous (AbdSc) adipocytes from participants with obesity and normal-weight participants were treated with endotoxin to assess in vitro changes in mitochondrial function and BRITE phenotype. Ex vivo human AbdSc AT from different groups of participants (normal-weight, obesity, pre- and 6 months post-bariatric surgery) were assessed for similar analyses including circulating endotoxin levels. RESULTS: Ex vivo AT analysis (lean & obese, weight loss post-bariatric surgery) identified that systemic endotoxin negatively correlated with BAT gene expression (p < 0.05). In vitro endotoxin treatment of AbdSc adipocytes (lean & obese) reduced mitochondrial dynamics (74.6% reduction; p < 0.0001), biogenesis (81.2% reduction; p < 0.0001) and the BRITE phenotype (93.8% reduction; p < 0.0001). Lean AbdSc adipocytes were more responsive to adrenergic signalling than obese AbdSc adipocytes; although endotoxin mitigated this response (92.6% reduction; p < 0.0001). CONCLUSIONS: Taken together, these data suggest that systemic gut-derived endotoxaemia contributes to both individual adipocyte dysfunction and reduced browning capacity of the adipocyte cell population, exacerbating metabolic consequences. As bariatric surgery reduces endotoxin levels and is associated with improving adipocyte functionality, this may provide further evidence regarding the metabolic benefits of such surgical interventions.
650    _2
$a lidé $7 D006801
650    12
$a diabetes mellitus 2. typu $7 D003924
650    12
$a endotoxemie $x metabolismus $7 D019446
650    _2
$a tukové buňky $x metabolismus $7 D017667
650    _2
$a obezita $x metabolismus $7 D009765
650    _2
$a lipopolysacharidy $7 D008070
650    _2
$a endotoxiny $x metabolismus $7 D004731
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Murphy, Alice M $u Department of Biosciences, School of Science and Technology, Nottingham Trent University, Nottingham, NG11 8NS, UK
700    1_
$a Younis, Awais Z $u Department of Biosciences, School of Science and Technology, Nottingham Trent University, Nottingham, NG11 8NS, UK
700    1_
$a Kyrou, Ioannis $u Warwickshire Institute for the Study of Diabetes, Endocrinology and Metabolism (WISDEM), University Hospitals Coventry and Warwickshire NHS Trust, Coventry, CV2 2DX, UK $u Centre for Sport, Exercise and Life Sciences, Research Institute for Health & Wellbeing, Coventry University, Coventry, CV1 5FB, UK $u Aston Medical School, College of Health and Life Sciences, Aston University, Birmingham, B4 7ET, UK $u Warwick Medical School, University of Warwick, Coventry, CV4 7AL, UK
700    1_
$a Vrbikova, Jana $u Institute of Endocrinology, Prague, Czech Republic
700    1_
$a Hainer, Vojtech $u Institute of Endocrinology, Prague, Czech Republic
700    1_
$a Sramkova, Petra $u OB Clinic, Prague, Czech Republic
700    1_
$a Fried, Martin $u OB Clinic, Prague, Czech Republic
700    1_
$a Ball, Graham $u Medical Technology Research Centre, Anglia Ruskin University, Cambridge, UK
700    1_
$a Tripathi, Gyanendra $u Human Sciences Research Centre, College of Life and Natural Sciences, University of Derby, Derby, DE22 1GB, UK
700    1_
$a Kumar, Sudhesh $u Warwickshire Institute for the Study of Diabetes, Endocrinology and Metabolism (WISDEM), University Hospitals Coventry and Warwickshire NHS Trust, Coventry, CV2 2DX, UK $u Warwick Medical School, University of Warwick, Coventry, CV4 7AL, UK
700    1_
$a McTernan, Philip G $u Department of Biosciences, School of Science and Technology, Nottingham Trent University, Nottingham, NG11 8NS, UK. philip.mcternan@ntu.ac.uk
700    1_
$a Christian, Mark $u Department of Biosciences, School of Science and Technology, Nottingham Trent University, Nottingham, NG11 8NS, UK. mark.christian@ntu.ac.uk
773    0_
$w MED00008190 $t BMC medicine $x 1741-7015 $g Roč. 21, č. 1 (2023), s. 154
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37076885 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230718 $b ABA008
991    __
$a 20230801133315 $b ABA008
999    __
$a ok $b bmc $g 1963911 $s 1198012
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 21 $c 1 $d 154 $e 20230419 $i 1741-7015 $m BMC medicine $n BMC Med $x MED00008190
GRA    __
$a BB/P008879/2 $p Biotechnology and Biological Sciences Research Council $2 United Kingdom
LZP    __
$a Pubmed-20230718

Najít záznam

Citační ukazatele

Možnosti archivace